Orchard Therapeutics plc

CITADEL ADVISORS LLC

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/14/2023

Shares

2,294,315

Value ($000)

851

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/14/2023	851	0.0%	2,294,315	12/31/2022
2022 Q3	11/14/2022	1,145	0.0%	2,290,342	9/30/2022
2022 Q2	8/15/2022	13	0.0%	21,409	6/30/2022
2022 Q1	5/16/2022	108	0.0%	151,307	3/31/2022
2021 Q4	2/14/2022	250	0.0%	189,439	12/31/2021
2021 Q3	11/15/2021	449	0.0%	195,265	9/30/2021
2021 Q2	8/16/2021	1,165	0.0%	265,509	6/30/2021
2021 Q1	5/21/2021	2,328	0.0%	320,682	3/31/2021
2020 Q4	2/16/2021	199	0.0%	46,030	12/31/2020
2020 Q3	11/16/2020	80	0.0%	19,479	9/30/2020
2020 Q2	8/14/2020	8,118	0.0%	1,353,114	6/30/2020
2020 Q1	5/15/2020	6,514	0.0%	865,045	3/31/2020
2019 Q4	2/14/2020	6,956	0.0%	505,877	12/31/2019